Ligand-directed signaling at the beta3-adrenoceptor produced by 3-(2-Ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate (SR59230A) relative to receptor agonists
- PMID: 17717109
- DOI: 10.1124/mol.107.035337
Ligand-directed signaling at the beta3-adrenoceptor produced by 3-(2-Ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate (SR59230A) relative to receptor agonists
Abstract
This study examines signaling pathways activated by the mouse beta(3)-adrenoceptor (AR) expressed in Chinese hamster ovary cells at high (CHObeta(3)H) or low (CHObeta(3)L) levels. Functional responses included extracellular acidification rate (ECAR), cAMP accumulation, and p38 mitogen-activated protein kinase (MAPK) or extracellular signal-regulated protein kinase 1/2 (Erk1/2) phosphorylation. (-)-Isoproterenol and the beta(3)-AR agonist (R, R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino]-propyl]1,3-benzodioxole-2,2-decarboxylate (CL316243) caused concentration-dependent increases in cAMP accumulation and ECAR in CHObeta(3)H and CHObeta(3)L cells. For cAMP accumulation, the beta(3)-AR ligand SR59230A was a partial agonist in CHObeta(3)H and an antagonist in CHObeta(3)L cells but for ECAR was an agonist at both expression levels. This suggested that SR59230A, which is normally regarded as an antagonist, can selectively activate pathways leading to ECAR. Examination of the pathways stimulated by (-)-isoproterenol, CL316243, and SR59230A for both ECAR and cAMP accumulation suggested that the cAMP pathway predominates in CHObeta(3)H cells, whereas p38 MAPK is a major contributor to ECAR in CHObeta(3)L cells and was the sole contributor to responses to SR59230A. Western blots of p38 MAPK and Erk1/2 phosphorylation confirmed that MAPKs are activated in CHObeta(3)H and CHObeta(3)L cells by CL316243 and SR59230A but that SR59230A has much higher efficacy. In addition, p38 MAPK phosphorylation displayed differences in drug potency and efficacy between CHObeta(3)H and CHObeta(3)L cells related to inhibition of the response by cAMP. Thus, CL316243 and SR59230A display reversed orders of efficacy for cAMP accumulation compared with Erk1/2 and p38 MAPK phosphorylation, providing a strong indication of ligand-directed signaling.
Comment in
-
Ligand-directed signaling: 50 ways to find a lover.Mol Pharmacol. 2007 Nov;72(5):1097-9. doi: 10.1124/mol.107.040923. Epub 2007 Aug 23. Mol Pharmacol. 2007. PMID: 17717108
Similar articles
-
Evidence for pleiotropic signaling at the mouse beta3-adrenoceptor revealed by SR59230A [3-(2-Ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate].J Pharmacol Exp Ther. 2005 Mar;312(3):1064-74. doi: 10.1124/jpet.104.076901. Epub 2004 Dec 1. J Pharmacol Exp Ther. 2005. PMID: 15574684
-
The beta3-adrenoceptor agonist 4-[[(Hexylamino)carbonyl]amino]-N-[4-[2-[[(2S)-2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]-phenyl]-benzenesulfonamide (L755507) and antagonist (S)-N-[4-[2-[[3-[3-(acetamidomethyl)phenoxy]-2-hydroxypropyl]amino]-ethyl]phenyl]benzenesulfonamide (L748337) activate different signaling pathways in Chinese hamster ovary-K1 cells stably expressing the human beta3-adrenoceptor.Mol Pharmacol. 2008 Nov;74(5):1417-28. doi: 10.1124/mol.108.046979. Epub 2008 Aug 6. Mol Pharmacol. 2008. PMID: 18684840
-
Functional domains of the mouse beta3-adrenoceptor associated with differential G protein coupling.J Pharmacol Exp Ther. 2005 Dec;315(3):1354-61. doi: 10.1124/jpet.105.091736. Epub 2005 Sep 6. J Pharmacol Exp Ther. 2005. PMID: 16144970
-
The odd sibling: features of β3-adrenoceptor pharmacology.Mol Pharmacol. 2014 Nov;86(5):479-84. doi: 10.1124/mol.114.092817. Epub 2014 Jun 2. Mol Pharmacol. 2014. PMID: 24890609 Review.
-
Advances in pharmacotherapy for obesity.Int J Obes Relat Metab Disord. 1998 Aug;22 Suppl 1:S13-6; discussion S17. Int J Obes Relat Metab Disord. 1998. PMID: 9758239 Review.
Cited by
-
Agonist-induced desensitisation of β3 -adrenoceptors: Where, when, and how?Br J Pharmacol. 2019 Jul;176(14):2539-2558. doi: 10.1111/bph.14633. Epub 2019 Apr 7. Br J Pharmacol. 2019. PMID: 30809805 Free PMC article. Review.
-
Factors influencing biased agonism in recombinant cells expressing the human α1A -adrenoceptor.Br J Pharmacol. 2017 Jul;174(14):2318-2333. doi: 10.1111/bph.13837. Epub 2017 Jun 10. Br J Pharmacol. 2017. PMID: 28444738 Free PMC article.
-
Preliminary Study on β3-Adrenoreceptor as Predictor Marker of Relapse in Ewing Sarcoma Patients.Biomedicines. 2020 Oct 13;8(10):413. doi: 10.3390/biomedicines8100413. Biomedicines. 2020. PMID: 33066095 Free PMC article.
-
β2-Adrenoceptor-mediated regulation of glucose uptake in skeletal muscle--ligand-directed signalling or a reflection of system complexity?Naunyn Schmiedebergs Arch Pharmacol. 2013 Sep;386(9):757-60. doi: 10.1007/s00210-013-0879-7. Epub 2013 May 9. Naunyn Schmiedebergs Arch Pharmacol. 2013. PMID: 23657252
-
GPCR systems pharmacology: a different perspective on the development of biased therapeutics.Am J Physiol Cell Physiol. 2022 May 1;322(5):C887-C895. doi: 10.1152/ajpcell.00449.2021. Epub 2022 Feb 23. Am J Physiol Cell Physiol. 2022. PMID: 35196164 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous